(Total Views: 443)
Posted On: 05/18/2021 9:35:46 AM
Post# of 148903
Re: KenChowder #90697
KenChowder wrote:
The FDA letter was shocking. I just assumed that if the FDA goes ahead and publishes a piece like that, it would be factually correct. But gradually I realized it's riddled with mistakes. I find that amazing.
my response:
The FDA went beyond risky and beyond reckless. Therefore, I must conclude the probability that the FDA was strongly coherced into not only publishing this letter, but also, strongly coherced into wording statements exactly as "directed". The FDA was pushed, threatened, forced to go over the line. The line I'm talking about is the line of "risk" where one recognizes that it is very unlikely they will get away with what they are doing. The letter says "no effect" upon the virus in CD10 Primary nor Secondary Endpoints. This is not an error, nor the result of a "rushed" document. It is an intentional "extreme" lie about the most important results of the trial, it is the "Silver Bullet Lie" intended to kill, to stop Leronlimab from all progress.
That lie contradicts all subsequent actions the FDA took for Leronlimab such as allowing eIND and Open Label to continue, and supporting collection of more data. Why collect more data if existing data shows "no effect". I say they'll be exposed, must be exposed, and due to the number of deaths, this could be next to the Holocaust as Scandals of The Century.
The FDA letter was shocking. I just assumed that if the FDA goes ahead and publishes a piece like that, it would be factually correct. But gradually I realized it's riddled with mistakes. I find that amazing.
my response:
The FDA went beyond risky and beyond reckless. Therefore, I must conclude the probability that the FDA was strongly coherced into not only publishing this letter, but also, strongly coherced into wording statements exactly as "directed". The FDA was pushed, threatened, forced to go over the line. The line I'm talking about is the line of "risk" where one recognizes that it is very unlikely they will get away with what they are doing. The letter says "no effect" upon the virus in CD10 Primary nor Secondary Endpoints. This is not an error, nor the result of a "rushed" document. It is an intentional "extreme" lie about the most important results of the trial, it is the "Silver Bullet Lie" intended to kill, to stop Leronlimab from all progress.
That lie contradicts all subsequent actions the FDA took for Leronlimab such as allowing eIND and Open Label to continue, and supporting collection of more data. Why collect more data if existing data shows "no effect". I say they'll be exposed, must be exposed, and due to the number of deaths, this could be next to the Holocaust as Scandals of The Century.
(8)
(0)Scroll down for more posts ▼
